Caitong International Asset Management’s Wave Life Sciences WVE Stock Holding History

Caitong International Asset Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$222K	Sell	38,196 -142,784	-79%	-$947K	0.03%	401
2026 Q1	$1.31M	Buy	180,980 +170,623	+1,647%	+$2.22M	0.24%	92
2025 Q4	$176K	Buy	+10,357	New	+$105K	0.04%	242
2025 Q2	–	Sell	-348	Closed	-$2.81K	–	2554
2025 Q1	$2.81K	Buy	+348	New	+$3.81K	﹤0.01%	1214

Other funds holding WVE

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Caitong International Asset Management's WVE Position: Q2 2026 in Review

Caitong International Asset Management reduced its Wave Life Sciences (WVE) stake by 79% in Q2 2026, selling an estimated $947K and leaving 38,196 shares worth $222K. The position accounts for 0.03% of the portfolio, ranked #401.

Caitong International Asset Management first reported a position in WVE in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.31M in Q1 2026. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Caitong International Asset Management held 38,196 shares of Wave Life Sciences worth $222K as of Q2 2026.
Caitong International Asset Management sold 142,784 Wave Life Sciences shares in Q2 2026, an estimated $947K.
Wave Life Sciences made up 0.03% of Caitong International Asset Management's portfolio in Q2 2026, its #401 holding.
Caitong International Asset Management first reported a position in Wave Life Sciences in Q1 2025 and has held it in 4 quarters since.
Caitong International Asset Management's Wave Life Sciences position peaked at $1.31M in Q1 2026.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.